Neuroprotective Effect of Curcumin-Loaded RGD Peptide-PEGylated Nanoliposomes.

Area of Science:

• Biomaterials Science
• Neuroscience
• Pharmacology

Background:

• Curcumin exhibits potent anti-inflammatory, antioxidant, and neuroprotective properties.
• Curcumin's therapeutic application is limited by poor solubility, bioavailability, and instability.
• Developing effective delivery systems is crucial for harnessing curcumin's neuroprotective potential.

Purpose of the Study:

• To develop and evaluate RGD peptide-PEGylated nanoliposomes from salmon lecithin for curcumin encapsulation.
• To assess the neuroprotective efficacy of curcumin-loaded nanoliposomes against amyloid-beta (Aβ) induced toxicity.
• To investigate the improved neuronal tolerance and pharmacokinetic profile of encapsulated curcumin.

Main Methods:

• Formulation of empty and curcumin-loaded nanoliposomes using salmon-derived lecithin.
• Characterization of nanoliposomes using Transmission Electron Microscopy, Dynamic Light Scattering, and Nanoparticle Tracking Analysis.
• In vitro assessment of cytotoxicity and neuroprotection using SH-SY5Y neuroblastoma cells treated with Aβ peptides.

Main Results:

• Salmon lecithin nanoliposomes were spherical, nanometric in size, and negatively charged.
• Curcumin-loaded nanoliposomes demonstrated improved neuronal tolerance compared to free curcumin.
• Pre-treatment with RGD peptide-PEGylated curcumin nanoliposomes significantly reduced Aβ-induced cell toxicity.

Conclusions:

• Salmon lecithin is a suitable material for developing RGD peptide-PEGylated nanoliposomes for drug delivery.
• These nanoliposomes enhance curcumin's neuroprotective efficacy and neuronal tolerance.
• The developed system shows promise for efficient curcumin delivery in neurodegenerative disease treatment.